[Form 4] Arteris, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Arteris, Inc. insider filing reports that Bayview Legacy, LLC, an entity managed by K. Charles Janac, sold 100,000 shares of Arteris common stock on 10/06/2025 under a 10b5-1 trading plan. The sales were executed in multiple transactions at weighted-average price $13.1045, with trade prices ranging from $12.50 to $13.85. After the disposition, Bayview Legacy, LLC is reported to beneficially own 9,739,071 shares, and Janac is deemed to have voting and dispositive power as the manager. Janac also filed a separate Form 4 reporting the same sale in his individual capacity.

Positive

• Transaction executed under a 10b5-1 plan, indicating pre-arranged timing rather than opportunistic insider trading
• Reporting transparency: filing discloses weighted-average price and price range and offers to provide trade-level detail on request
• Large retained stake: Bayview Legacy, LLC still beneficially owns 9,739,071 shares after the sale

Negative

• Reduction in holdings by 100,000 shares, representing a realized disposition by an insider-controlled entity

Insights

Corporate Governance Analyst

Insider sale under a pre-established trading plan reduces timing concerns but changes ownership stake.

The sale of 100,000 shares was executed pursuant to a 10b5-1 plan adopted on 03/05/2025, which indicates the transactions were pre-planned rather than opportunistic. The filing also clarifies that the reported price is a weighted average of multiple trades between $12.50 and $13.85

Key dependencies include the unchanged beneficial ownership of 9,739,071 shares and the manager role of K. Charles Janac. Monitor next periodic filings for further planned sales or changes in beneficial ownership within a 90-180 day horizon.

Equity Markets Analyst

Sale size is small relative to total holdings but may be notable for liquidity events.

The reported disposal of 100,000 shares at a weighted-average price of $13.1045 represents a discrete liquidity event; however, the group continues to hold a large position of 9,739,071 shares after the sale. The filing discloses the price range and offers to provide granular trade-level details on request.

Near-term market impact is likely limited given retained holdings; follow subsequent Form 4s for cumulative sale trends over the next quarter.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bayview Legacy, LLC

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CA 95008

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/06/2025		S(1)(2)		100,000	D	$13.1045(3)	9,739,071	I	See Footnote(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on March 5, 2025.

2. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.

3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $12.50 to $13.85 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.

Remarks:

	/s/ K. Charles Janac	10/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Arteris (AIP) insider Bayview Legacy, LLC report on Form 4?

Bayview Legacy, LLC reported the sale of 100,000 shares on 10/06/2025 under a 10b5-1 plan at a weighted-average price of $13.1045.

How many Arteris shares does Bayview Legacy, LLC own after the sale?

The filing reports beneficial ownership of 9,739,071 shares following the reported transaction.

Was the sale executed as part of a pre-established trading plan?

Yes. The sales were made pursuant to a 10b5-1 trading plan adopted on 03/05/2025 by the manager of Bayview Legacy, LLC.

What price range did the trades occur at for the reported sale?

Trades occurred at prices ranging from $12.50 to $13.85, with a weighted-average of $13.1045.

Did K. Charles Janac file separately for the same transaction?

Yes. The filing states that K. Charles Janac filed a separate Form 4 in his individual capacity reporting the same transaction.